Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-02

Clinical Trial Update: Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery [NA]

View source ↗

Summary

A clinical trial evaluating preoperative topical gatifloxacin for prevention of endophthalmitis after cataract surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gatifloxacin (Gatifloxacin)

Snippet

Sponsor: Queen's University | Conditions: Endophthalmitis | NA | Status: WITHDRAWN